Sculptor Capital’s Terns Pharmaceuticals TERN Stock Holding History

Sculptor Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-380,000	Closed	-$20M	–	442
2026 Q1	$20M	Buy	+380,000	New	+$15.6M	0.21%	104

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sculptor Capital's TERN Position: Q2 2026 in Review

Sculptor Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 380,000 shares — an estimated $20M sold.

Sculptor Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $20M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Sculptor Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Sculptor Capital sold 380,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $20M.
Sculptor Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Sculptor Capital's Terns Pharmaceuticals position peaked at $20M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.